Last reviewed: July 1, 2026
Last updated: July 1, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Ozempic's FDA-approved dosing protocol uses specific weekly increments: 0.25 mg, 0.5 mg, 1 mg, and 2.4 mg. Many patients wonder whether intermediate doses like 1.25 mg are available or appropriate. Understanding dosing flexibility helps you work with your prescriber to find the right therapeutic level for your individual needs.
Standard Ozempic Dosing Schedule and Limitations
Ozempic's approved treatment protocol follows a structured escalation pattern over 4-6 weeks. Patients typically begin at 0.25 mg once weekly, advancing to 0.5 mg in week 2, then 1 mg in week 3, and finally 2.4 mg for maintenance therapy. This step-wise approach helps the body adapt while minimizing gastrointestinal side effects. However, the predetermined increments leave no room for intermediate adjustments if a patient responds well at a dose between the standard steps.
The brand-name formulation comes in pre-filled pens manufactured at fixed concentrations. A 1.25 mg dose does not exist in the standard Ozempic product line because the pens are designed specifically for the four approved dose strengths. Some patients stabilize at lower maintenance doses or need adjustment between the standard intervals, creating a clinical gap for those seeking personalized dosing flexibility.
Why Intermediate Dosing Matters in Weight Loss Treatment
Individual responses to GLP-1 therapy vary significantly based on metabolism, genetic factors, and gastrointestinal sensitivity. A patient who reaches their target weight loss at 0.75 mg or benefits from a 1.5 mg intermediate step experiences unnecessary side effects if forced to jump to the next standard dose. Real-world clinical experience shows that some patients achieve optimal results with doses that fall outside the manufacturer's rigid framework. Precision in dose adjustment correlates with better tolerability and faster achievement of therapeutic goals.
Compounded semaglutide formulations allow prescribers to titrate doses in smaller increments that match each patient's physiological response. Rather than waiting for the next standard step or tolerating unnecessary effects, patients can move through customized dosing schedules that reflect their unique metabolism and needs. This flexibility represents a significant advantage over rigid, pre-determined dosing protocols.
Compounded Semaglutide vs. Brand-Name Ozempic Dosing
PlexusDx offers compounded semaglutide injections prepared by licensed 503A compounding pharmacies, which can be formulated at any prescribed dose strength. Unlike the brand-name pens limited to four increments, compounded formulations provide prescribers complete freedom to specify exact dosing based on patient response and tolerance. A patient needing 1.25 mg, 1.75 mg, or any intermediate dose can receive that precise amount without compromise. The medication delivers the same active pharmaceutical ingredient as the branded version but with customization that matches modern precision medicine principles.
Compounded semaglutide from PlexusDx starts at $149 per month with the pricing structure designed to remain flat regardless of dose strength—meaning your dose may increase as your treatment progresses, but your monthly cost stays consistent. This pricing transparency removes the financial barrier to optimal dose adjustments that some patients face with other providers or insurance-based models.
Personalized Dosing and the Role of Genetic Insights
Response to GLP-1 therapy is influenced by genetic variation in peptide-pathway genes including GLP1R, GIPR, FTO, and MC4R. The Precision Peptide Genetic Test offered by PlexusDx examines 14 pathways and 150+ genetic insights to identify how your body's signaling systems respond to semaglutide therapy. Patients with specific genetic variants may achieve optimal results at doses that differ from population averages—reinforcing the clinical value of personalized dosing beyond standard increments.
Combining compounded semaglutide with genetic testing allows your prescriber to make informed decisions about starting doses, escalation speed, and optimal maintenance levels. A patient with lower GLP1R expression may benefit from a more gradual titration or a higher final dose, while another with enhanced GIPR sensitivity might reach therapeutic effect at a lower intermediate dose. This integration of genetics and pharmacology represents the future of precision weight loss treatment.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is a 1.25 mg dose of Ozempic available?
Standard brand-name Ozempic does not come in a 1.25 mg formulation because the pens are manufactured at four fixed strengths. However, compounded semaglutide from PlexusDx can be prepared at any dose your prescriber deems appropriate, including 1.25 mg, offering the flexibility that brand-name pens cannot provide.
How much weight can you lose on 1.25 mg of semaglutide?
Weight loss outcomes depend on individual metabolism, adherence, diet, and exercise—not dose alone. Clinical trials show semaglutide produces meaningful weight reduction across doses, but individual response varies. Your prescriber adjusts your dose based on your personal response and tolerance, which may include an intermediate dose like 1.25 mg.
What does compounded semaglutide from PlexusDx cost?
PlexusDx Compounded Semaglutide Injection starts at $149 per month and remains flat across all dose strengths—your price won't change even as your prescription dose increases during treatment. No insurance is required, and the medication is HSA/FSA eligible.
Are there safety concerns with intermediate semaglutide doses?
Semaglutide has a wide therapeutic window, and intermediate doses like 1.25 mg are as safe as standard doses when prescribed by a licensed healthcare provider. Compounded medications from PlexusDx come from licensed 503A compounding pharmacies and meet rigorous quality standards. Common side effects are gastrointestinal in nature and typically diminish over time.
How can genetic testing help determine my ideal semaglutide dose?
The PlexusDx Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence how your body responds to semaglutide therapy. Understanding your genetic predispositions allows your prescriber to recommend starting doses, escalation timing, and maintenance levels tailored to your biology—potentially including intermediate doses that optimize your individual results.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
When Do You See Weight Loss on Ozempic?
Is Ozempic Worth Taking? A Guide to Benefits and Risks